Drawing for GYNALAC

USPTO serial 87263634

GYNALAC

Reviewed by CopyMark Law Group

Reg. 5527387Status 702Registered
Filing date
Status date
Registration date
Jul 31, 2018
Examiner
JOHN, CRISTEL M
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with GYNALAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ellen A. Andelman

Ellen A. Andelman Moore & Van Allen PLLC100 North Tryon StreetSuite 4700Charlotte, NC 28202-4003

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical grade vaginal gel, acting as a pH regulator and designed to treat and prevent symptoms of Bacterial Vaginosis/ Vaginal Atrophy, namely, abnormal discharge and odor, while providing a moisturizing effect that promotes wound healing and relieves symptoms of dryness, itching, burning, painful sexual activity and overall vaginal discomfortACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 15, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 15, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 15, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 31, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Apr 24, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 31, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 12, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 31, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 15, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 15, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 25, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 18, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 18, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 18, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 18, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Oct 18, 2017CNSISUSPENSION INQUIRY WRITTEN—
Oct 13, 2017RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 11, 2017ALIEASSIGNED TO LIE—
Mar 29, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 29, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Mar 29, 2017CNSLSUSPENSION LETTER WRITTEN—
Mar 13, 2017DOCKASSIGNED TO EXAMINER—
Dec 14, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 13, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance